Commissioner of health direction to study and report on activities to support innovations in cell and gene therapy to treat rare diseases

This bill directs Minnesota's commissioner of health to conduct a comprehensive study on how the state can support innovations in cell and gene therapies for treating rare diseases. The study will examine current research capacity, healthcare infrastructure, workforce needs, funding options, and access barriers across the state, with input from patients, healthcare providers, industry experts, and other stakeholders. By January 1, 2028, the commissioner must submit a report to the legislature with findings and recommendations for strategic investments, policy changes, and regulatory actions to advance these therapies. The bill also defines key terms such as cell and gene therapy and rare disease to establish a clear framework for the study.